Seres Therapeutics (MCRB) Interest & Investment Income (2015 - 2026)
Seres Therapeutics (MCRB) posted Interest & Investment Income of $325000.0 for Q1 2026, down 26.97% sequentially from $445000.0 in Q4 2025, and down 47.41% YoY from $618000.0 in Q1 2025.
Seres Therapeutics (MCRB) Interest & Investment Income (2015 - 2026) Analysis & Trends
Seres Therapeutics has reported Interest & Investment Income for 12 years, with the latest figure at $325000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 47.41% year-over-year to $325000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 287.77% YoY) and the FY2025 annual result came in at $2.2 million, changed N/A from the prior year.
- Interest & Investment Income slipped to $325000.0 in Q1 2026 per MCRB's latest filing, from $445000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.6 million in Q3 2023 and troughed at -$5.3 million in Q4 2023.
- A 5-year average of $227941.2 and a median of $546000.0 in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income sank 476.24% in 2023, then surged 13633.33% in 2024.
- Over 5 years, Interest & Investment Income stood at $1.4 million in 2022, then tumbled by 476.24% to -$5.3 million in 2023, then surged by 33.65% to -$3.5 million in 2024, then jumped by 112.61% to $445000.0 in 2025, then dropped by 26.97% to $325000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $325000.0, $445000.0, and $618000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | 181,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 181,000.00 |
| Mar 31, 2026 | 325,000.00 |
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 546,000.00 |
| Mar 31, 2025 | 618,000.00 |
| Dec 31, 2024 | -3.53 Mn |
| Sep 30, 2024 | 652,000.00 |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | -5.32 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 395,000.00 |
| Mar 31, 2022 | 384,000.00 |
| Dec 31, 2021 | 485,000.00 |
| Sep 30, 2021 | 590,000.00 |